as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹3,945.3
Change
-26.0 (-0.65%)
Open
₹3,980.0
Prev. Close
₹3,971.3
Day High
₹4,010.1
Day Low
₹3,926.0
Volume Analysis
Traded
3,342
Delivered
1,800
Delivery %
53.86%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Promoter holding is rising
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹4,079.04 | ₹4,044.57 | ₹3,994.94 | ₹3,960.47 | ₹3,910.84 | ₹3,876.37 | ₹3,826.74 |
| Fibonacci | ₹4,044.57 | ₹4,012.44 | ₹3,992.6 | ₹3,960.47 | ₹3,928.34 | ₹3,908.5 | ₹3,876.37 |
| Camarilla | ₹3,968.43 | ₹3,960.72 | ₹3,953.01 | ₹3,960.47 | ₹3,937.59 | ₹3,929.88 | ₹3,922.17 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-13.5%
1 Week
-1.31%
1 Month
-6.37%
3 Months
-14.18%
6 Months
-13.02%
1 Year
-20.14%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Sanofi Cons Healthc Ind L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 63/100. The strongest factor is Corporate Governance (100/100), while Institutional Ownership (25/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising. FII holding has been falling.
TopFund Score — Fundamentals Quality
63/100 — AverageData confidence: 60/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Corporate Governance
Institutional Ownership
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.
Board approved Q2 FY26 results: revenue ₹2,357 million, net profit ₹919 million; H1 revenue ₹4,649 million.
Source: BSE regulatory filings, via Screener.in.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Public | 10.98% | 10.56% | 9.84% | 9.59% | 8.59% | 8.58% | 8.57% | 8.41% | 8.28% |
| Promoters | 60.4% | 60.4% | 60.4% | 60.4% | 71.27% | 71.27% | 71.27% | 71.27% | 71.27% |
| FII | 6.03% | 5.22% | 4.42% | 4.52% | 3.24% | 2.94% | 2.83% | 2.76% | 2.6% |
| DII | 22.6% | 23.83% | 25.35% | 25.48% | 16.89% | 17.21% | 17.33% | 17.57% | 17.85% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Sanofi Cons Healthc Ind L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 444,405 | 35.2 | 5.32 | 16.0% |
| Divi S Laboratories Ltd | 255,487 | 85.8 | 15.25 | 16.5% |
| Torrent Pharmaceuticals L | 189,746 | 85.0 | 20.11 | 27.4% |
| Apollo Hospitals Enter. L | 128,055 | 60.9 | 13.51 | 21.2% |
| Zydus Lifesciences Ltd | 120,089 | 24.7 | 4.48 | 21.2% |
| Cipla Ltd | 111,060 | 31.0 | 3.23 | 11.6% |
Which Mutual Funds Hold Sanofi Cons Healthc Ind L?
Frequently Asked Questions about Sanofi Cons Healthc Ind L
Sanofi Cons Healthc Ind L (SANOFICONR) closed at ₹3,945.3 on NSE on 25 September 2026, down 26.0 (0.65%) from the previous close.
Sanofi Cons Healthc Ind L trades on the NSE (National Stock Exchange of India) under the symbol SANOFICONR.
Sanofi Cons Healthc Ind L has a TopFund Quality Score of 63/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Sanofi Cons Healthc Ind L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.